Forecasting Covid-19 Mortality in Cameroon

Abstract

In this study, the ANN approach was applied to analyze COVID-19 deaths in Cameroon. The employed data covers the period 1January 2020-20 April 2020 and the out-of-sample period ranges over the period 21 April -31 August 2021. The residuals and forecast evaluation criteria (Error, MSE and MAE) of the applied model indicate that the model is quite stable. The results of the study indicate that daily COVID-19 deaths in Cameroon are likely to be less than 5 deaths per day (close to zero) over the out-of-sample period. Therefore there is need for the government of Cameroon to ensure adherence to safety guidelines while continuing to create awareness about the COVID-19 pandemic and scaling up COVID-19 vaccination.

Country : Zimbabwe

1 Dr. Smartson. P. NYONI2 Mr. Thabani NYONI3 Mr. Tatenda. A. CHIHOHO

  1. ZICHIRe Project, University of Zimbabwe, Harare, Zimbabwe
  2. SAGIT Innovation Center, Harare, Zimbabwe
  3. Independent Health Economist, Harare, Zimbabwe

IRJIET, Volume 5, Issue 6, June 2021 pp. 163-168

doi.org/10.47001/IRJIET/2021.506031

References

  1. CDC (2020). The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. China CDC Weekly 2, 113–122
  2. Government Response Strategy to the Coronavirus Pandemic (COVID-19)|Prime Minister’s Office (2020). Available online: https:// www.spm.gov.cm/site/?q=en/content/government-response-strategy-coronavirus-pandemic-covid-19.
  3. Siewe Fodjo., J.N Ngarka., L Njamnshi., W.Y Nfor., L.N Mengnjo., M.K Mendo., E.L Angwafor., S.A Basseguin., J.G.A Nkouonlack., C Njit., E.N (2021). COVID-19 Preventive Behaviours in Cameroon: A Six-Month Online National Survey. Int. J. Environ. Res. Public Health 2021, 18, 2554.
  4. Tang. B et al (2020).  An updated estimation of the risk of transmission of the novel coronavirus (2019-nCoV). Infectious Disease Modelling 5, 248–255.
  5. Tang. B et al (2020). Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J. Clinical Med. 9, 462.
  6. Tcheutchoua., D N Tankeu., A.T Angong., D.L.W  Agoons., B.B  Nguemnang., N.Y.Y  Djeunga., H.C.N Kamgno J (2020). Unexpected low burden of coronavirus disease 2019 (COVID-19) in sub-Saharan Africa region despite disastrous predictions: Reasons and perspectives. Pan Afr. Med. J. 2020, 37
  7. Van Damme., W Dahake., R Delamou., A Ingelbeen., B Wouters., E Vanham., G van de Pas., R Dossou., J P Ir., P Abimbola., S (2020). The COVID-19 pandemic: Diverse contexts; different epidemics—how and why? BMJ Glob. Health 2020, 5, e003098.
  8. Wang D et al (2020).  Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323, 1061–1069.
  9. Wang H et al (2020). Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China. Cell Discovery 6, 76.
  10. Wang. W et al (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virology 92, 441–447
  11. WHO (2021) Coronavirus Disease (COVID-19). Available online: https://covid19.who.int